Tuberculosis (TB)

Research for TB elimination

Laboratory personnel, IARC - International Agency for Research on Cancer
WHO/EURO/Gilles Reboux

21 March 2019 - The World Health Organization’s (WHO) End TB Strategy aims to end the global TB epidemic by 2030. It targets a 90% reduction in TB mortality, a 80% decline in TB incidence and zero catastrophic costs for TB-affected households. To reach these ambitious targets, ‘Intensified research and innovation’ is needed to develop more effective interventions to detect, cure and prevent TB. This constitutes the third pillar of the End TB Strategy.

fact buffet


3rapid diagnostic tests were made available in the past decade, and diagnostic tools are under development.

Global TB report 2018


12vaccine candidates are in clinical trial

Global TB report 2018


2new drugs were introduced in the past decade, and another eight new or repurposed drugs are under development

Global TB report 2018

Process overview: Development of a WHO global strategy on TB research and innovation

WHO is developing a Global Strategy for TB Research and Innovation (Global Strategy) in consultation with Member States, Civil Society, partners and other key stakeholders, for consideration by the Executive Board at its 146th session in January 2020.

Laboratory research

WHO, with contributions from many stakeholders, has developed a Global Action Framework for TB Research to foster high-quality TB research over the next 10 years (2015 to 2025), both at country and global levels.

To strengthen TB research in low- and middle-income countries most affected by TB, WHO supports developing and implementing a national TB research plan.

Laboratory personnel, IARC - International Agency for Research on Cancer
WHO/EURO/Gilles Reboux

To promote and enhance TB research globally, WHO encourages building strong research partnerships and networks and securing robust funding for research.
These are needed along all research spectrum (from basic science to operational research) and requires a strong and self-sustained TB research community.

News, events, and meeting reports